- Home
- VTYX vs QMCO Comparison
VTYX vs QMCO Comparison
Compare VTYX & QMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTYX
- QMCO
- Stock Information
- Founded
- VTYX 2018
- QMCO 1980
- Country
- VTYX United States
- QMCO United States
- Employees
- VTYX N/A
- QMCO 635
- Industry
- VTYX Medicinal Chemicals and Botanical Products
- QMCO Electronic Components
- Sector
- VTYX Health Care
- QMCO Technology
- Exchange
- VTYX Nasdaq
- QMCO Nasdaq
- Market Cap
- VTYX 154.9M
- QMCO 157.2M
- IPO Year
- VTYX 2021
- QMCO N/A
- Fundamental
- Price
- VTYX $3.65
- QMCO $12.69
- Analyst Decision
- VTYX Buy
- QMCO Hold
- Analyst Count
- VTYX 3
- QMCO 2
- Target Price
- VTYX $10.00
- QMCO $19.00
- AVG Volume (30 Days)
- VTYX 1.5M
- QMCO 4.1M
- Earning Date
- VTYX 11-06-2025
- QMCO 11-12-2025
- Dividend Yield
- VTYX N/A
- QMCO N/A
- EPS Growth
- VTYX N/A
- QMCO N/A
- EPS
- VTYX N/A
- QMCO N/A
- Revenue
- VTYX N/A
- QMCO $266,079,000.00
- Revenue This Year
- VTYX N/A
- QMCO N/A
- Revenue Next Year
- VTYX N/A
- QMCO $5.30
- P/E Ratio
- VTYX N/A
- QMCO N/A
- Revenue Growth
- VTYX N/A
- QMCO N/A
- 52 Week Low
- VTYX $0.78
- QMCO $2.88
- 52 Week High
- VTYX $4.05
- QMCO $90.64
- Technical
- Relative Strength Index (RSI)
- VTYX 62.22
- QMCO 63.22
- Support Level
- VTYX $3.48
- QMCO $10.92
- Resistance Level
- VTYX $4.04
- QMCO $15.33
- Average True Range (ATR)
- VTYX 0.30
- QMCO 1.53
- MACD
- VTYX 0.04
- QMCO 0.15
- Stochastic Oscillator
- VTYX 72.93
- QMCO 60.84
About VTYX Ventyx Biosciences Inc.
Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.
About QMCO Quantum Corporation
Quantum Corp is a United States-based company that delivers end-to-end data management solutions designed for unstructured data in the era of artificial intelligence (AI). It provides one of the comprehensive and cost-efficient solutions for the entire data lifecycle. The group provides solutions for video, images, audio, and other large files because this unstructured data represents. Its portfolio of products includes primary storage software and systems, secondary storage software and systems, as well as devices and media. The group operates in three geographic regions: Americas, Europe, the Middle East, and Africa (EMEA), and Asia Pacific (APAC).